Massive Bio Inc., a trailblazing entity in the realm of digital health technology, proudly announces a pivotal advancement in clinical trial recruitment, fortified by a strategic relationship with Evernorth Health, Inc (ENI).
COMISAIR study is now the longest prospective real-world CGM study ever conducted, demonstrating significant and continued HbA1c reduction for patients using real-time CGM over seven years.1 New data shows the Dexcom ONE CGM system delivers a clinic...
BioAlberta has published its 2023 State of the Industry (SOI) report. This year’s report includes new insights and trends from the industry to reflect market conditions and the growth of the sector. The report’s resu...
Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, with $150 million under management, today announced the launch...
Sensor specialist startup Neuranics has secured a $2.3 million investment led by Par Equity.
The TMC Netherlands BioBridge marks the fifth strategic international partnership forged by TMC since 2016HOUSTON--(BUSINESS WIRE)--Texas Medical Center (TMC) and Health~Holland, Top Sector Life Sciences & Health (LSH) launched a groundbreaking Bi...
Accelerator Life Science Partners (ALSP), an early-stage life science accelerator and investmen...
New research shows UK doctors the least satisfied with their career choice compared to France, Germany, Italy, and Spain 8 in 10 say working in the NHS has become harder in the past year The vast majority of doctors are unhappy with their pay Just...
The "Global Congenital Adrenal Hyperplasia Treatment Market Report and Forecast 2023-2031" report has been added to ResearchAndMarkets.com's offering. The global congenital adrenal hyperplasia treatment market is poised for sub...
Mobile ecosystem brings together key partners to drive ROI through holistic offeringsATLANTA--(BUSINESS WIRE)--Gozio Health, an open, industry-leading, location-aware digital health platform, today announced it has launched a marketplace of vendors to...